- All > Medicine Information and Evidence for Policy > Medicines Policy
- All > Medicine Access and Rational Use > Supply Management
- All > Quality and Safety: Medicines > Regulatory Support
- Keywords > assessment of the pharmaceutical situation
- Keywords > drug supply
- Keywords > national essential drug programmes
- Keywords > national medicines policy - development
- Keywords > national pharmaceutical policy
- Keywords > procurement - national systems
- Keywords > rational medicine use (RMU)
- Keywords > regulatory control
- Keywords > use of essential drugs
(1989; 1 page)
The Colombian Government carried out an investigative study of the pharmaceutical situation in 1988 with the help of the WHO and the Pan American Health Organization. This study led to the formation of a national essential drugs strategy. Colombia has experienced major change in the past few decades, including the doubling of its population in 30 years and a shift toward urbanization. Effects of these changes on health include different leading causes of death, decreased access to health services, a shortage in doctors, and less affordable medicines. The new strategy aims to create legislation, rationalize production to respond to health needs, restructure the drug marketing sector and strengthen the public sector supply system to address these problems. The European Economic Community and WHO/PAHO will both fund the strategy and provide technical assistance for three years. Plans also called for the strengthening of the Ministry of Health of Colombia so that it may better support the implementation of the new policy. Several specific measures for the national essential drugs programme are outlined in the article.
Abstract written by M. Tobin, 2013.